Training activity information
Details
Attend and present a case to be discussed and reviewed in a multidisciplinary team meeting with other healthcare professionals
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- Consider the role of MDT meetings in the diagnosis, monitoring, and management of haematological malignancies. What information needs to be summarised for effective discussion?
- What information is typically required for cases being presented at an MDT meeting for haematological malignancies (e.g., patient history, laboratory results, genomic findings, imaging)? What is the typical format for presenting a case? Who are the key professionals involved in these meetings, and what are their roles?
- How are genomic findings integrated into clinical decision-making in the MDT setting? What are the different perspectives that various healthcare professionals bring to the discussion? How can you effectively communicate complex genomic information to a diverse audience?
- Review relevant patient data and reports, focusing on the key information to present. Consider potential questions that might arise during the meeting and how the information you prepare can help address them. Think about how you can contribute effectively to the discussion and learn from the perspectives of other team members.
In action
- Pay attention to how you are presenting the case (e.g., the order of information, the clarity of your explanations, how you are highlighting key genomic findings). Why are you structuring your presentation in this way?
- What decisions are you making in the moment as you respond to questions or comments from other MDT members?
- What aspects of communicating complex genomic information to this multidisciplinary audience feel more natural, and what requires more conscious effort to ensure clarity and understanding?
- How effectively are you conveying the relevant information about the case to facilitate discussion and decision-making?
- What challenges are you facing in presenting the case or understanding the perspectives of other team members? (e.g., time constraints, technical jargon, differing opinions).
- What are you learning about the collaborative process and the integration of different specialties in patient management as the meeting unfolds?
- Are there alternative ways you could explain a particular genomic finding to ensure better understanding among the team?
- What support or clarification might you need from other team members to understand their perspectives or the rationale behind certain treatment decisions?
On action
- What were the key aspects of the cases you presented? How did other healthcare professionals (e.g., clinicians, pathologists) respond to your presentation and the case details? What were the key discussion points and decisions made during the multidisciplinary team (MDT) meeting regarding the cases you presented?
- How did the experience of presenting cases in an MDT enhance your communication and presentation skills? What did you learn about the perspectives and information needs of other healthcare professionals in the context of haematological malignancies? How did the MDT discussion contribute to your understanding of the diagnostic and management pathways for these cases? What did you learn about the importance of integrated reporting and collaboration within a multidisciplinary team?
- What aspects of your presentation style or case preparation could be improved for future MDT meetings? How will you apply your understanding of the MDT process in your future interactions with other healthcare professionals? What actions will you take to further develop your skills in presenting complex scientific information to a multidisciplinary audience? What support or feedback would be beneficial for improving your contributions to MDT meetings?
Beyond action
- Have you presented cases in subsequent MDT meetings? How did those experiences compare with this initial one? What did you do differently?
- Have you discussed the dynamics and effectiveness of MDT meetings with colleagues? Has this provided new insights into your role in the team?
- Reflecting on your ‘reflect-on-action’, did the outcomes of the cases you presented align with the MDT’s decisions? Have you followed up on these cases and learned from their progression?
- How has your ability to communicate scientific information clearly and concisely to a multidisciplinary audience improved since this DTA?
- Has your understanding of the perspectives and information needs of different healthcare professionals influenced how you prepare for and contribute to other meetings or discussions?
- How will you continue to develop your skills in presenting complex cases and participating effectively in MDT meetings?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 3 |
Outcome
Evaluate the urgency of testing for particular haematological malignancies to inform management decisions. |
| # 4 |
Outcome
Analyse, interpret and prepare interpretive reports for common haematological malignancies, including results for somatic variants, clonality, and somatic hypermutation. |
| # 5 |
Outcome
Interpret the associated IQC and EQA of the laboratory tests for investigation of haematological malignancies. |
| # 6 |
Outcome
Practice with the relevant specialties for the diagnosis, monitoring and management of haematological malignancies. |